Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Susanna Schraen‐Maschke"'
Autor:
Sylvain Lehmann, Susanna Schraen-Maschke, Luc Buée, Jean-Sébastien Vidal, Constance Delaby, Christophe Hirtz, Frédéric Blanc, Claire Paquet, Bernadette Allinquant, Stéphanie Bombois, Audrey Gabelle, Olivier Hanon, for the Alzheimer’s Disease Neuroimaging Initiative (ADNI)
Publikováno v:
Molecular Neurodegeneration, Vol 19, Iss 1, Pp 1-14 (2024)
Abstract Background Current AT(N) stratification for Alzheimer’s disease (AD) accounts for complex combinations of amyloid (A), tau proteinopathy (T) and neurodegeneration (N) signatures. Understanding the transition between these different stages
Externí odkaz:
https://doaj.org/article/c860af25033746cb82e1ae7cdbcb2d80
Autor:
Constance Delaby, Olivier Bousiges, Damien Bouvier, Catherine Fillée, Anthony Fourier, Etienne Mondésert, Nicolas Nezry, Souheil Omar, Isabelle Quadrio, Benoit Rucheton, Susanna Schraen-Maschke, Vincent van Pesch, Stéphanie Vicca, Sylvain Lehmann, Aurelie Bedel
Publikováno v:
Frontiers in Aging Neuroscience, Vol 14 (2022)
Neurological biomarkers are particularly valuable to clinicians as they can be used for diagnosis, prognosis, or response to treatment. This field of neurology has evolved considerably in recent years with the improvement of analytical methods, allow
Externí odkaz:
https://doaj.org/article/b931b35796fd4807bbef259aa2ce127f
Autor:
Sylvain Lehmann, Susanna Schraen-Maschke, Jean-Sébastien Vidal, Constance Delaby, Frédéric Blanc, Claire Paquet, Bernadette Allinquant, Stéphanie Bombois, Audrey Gabelle, Olivier Hanon
Publikováno v:
Journal of Neurology, Neurosurgery & Psychiatry. 94:411-419
ObjectivesPlasma P-tau181 is an increasingly established diagnostic marker for Alzheimer’s disease (AD). Further validation in prospective cohorts is still needed, as well as the study of confounding factors that could influence its blood level.Met
Autor:
Emmanuelle Duron, Jean-Sébastien Vidal, Dominique Grousselle, Audrey Gabelle, Sylvain Lehmann, Florence Pasquier, Stéphanie Bombois, Luc Buée, Bernadette Allinquant, Susanna Schraen-Maschke, Christiane Baret, Anne-Sophie Rigaud, Olivier Hanon, Jacques Epelbaum
Publikováno v:
Frontiers in Aging Neuroscience, Vol 11 (2019)
Externí odkaz:
https://doaj.org/article/c28a93e9496345a0a90227c11cc8cedd
Autor:
Robert Jr Laforce, Caroline Dallaire-Théroux, Annie M. Racine, Gersham Dent, Cristian Salinas-Valenzuela, Elizabeth Poulin, Anne-Marie Cayer, Daphnée Bédard-Tremblay, Thierry Rouleau-Bonenfant, Frédéric St-Onge, Susanna Schraen-Maschke, Jean-Mathieu Beauregard, Nicolas Sergeant, Jack Puymirat
Publikováno v:
Journal of Neurology. 269:3579-3587
Objective To investigate Tau pathology using multimodal biomarkers of neurodegeneration and neurocognition in participants with myotonic dystrophy type 1 (DM1). Methods We recruited twelve participants with DM1 and, for comparison, two participants w
Autor:
Sylvain Lehmann, Susanna Schraen‐Maschke, Jean‐Sébastien Vidal, Bernadette Allinquant, Stéphanie Bombois, Audrey Gabelle, Olivier Hanon
Publikováno v:
Alzheimer's & Dementia.
Autor:
Emmanuelle Duron, Jean-Sébastien Vidal, Dominique Grousselle, Audrey Gabelle, Sylvain Lehmann, Florence Pasquier, Stéphanie Bombois, Luc Buée, Bernadette Allinquant, Susanna Schraen-Maschke, Christiane Baret, Anne-Sophie Rigaud, Olivier Hanon, Jacques Epelbaum
Publikováno v:
Frontiers in Aging Neuroscience, Vol 10 (2018)
A combination of low cerebrospinal fluid (CSF) Amyloid β1–42 (Aβ1–42) and high Total-Tau (T-Tau) and Phosphorylated-Tau (P-Tau) occurs at a prodromal stage of Alzheimer’s disease (AD) and recent findings suggest that network abnormalities and
Externí odkaz:
https://doaj.org/article/c2546e5c9f8a4a99a9fe2b92399fd965
Autor:
Constance, Delaby, Olivier, Bousiges, Damien, Bouvier, Catherine, Fillée, Anthony, Fourier, Étienne, Mondésert, Nicolas, Nezry, Souheil, Omar, Isabelle, Quadrio, Benoit, Rucheton, Susanna, Schraen-Maschke, Vincent, van Pesch, Stéphanie, Vicca, Sylvain, Lehmann, Aurélie, Bedel
Publikováno v:
Annales de biologie clinique. 80(5)
Neurological biomarkers are of great use for clinicians, as they can be used for numerous purposes: guiding clinical diagnosis, estimating prognosis, assessing disease stage and monitoring progression or response to treatment. This field of neurology
Autor:
Constance, Delaby, Olivier, Bousiges, Damien, Bouvier, Catherine, Fillée, Anthony, Fourier, Étienne, Mondésert, Nicolas, Nezry, Souheil, Omar, Isabelle, Quadrio, Benoit, Rucheton, Susanna, Schraen-Maschke, Vincent, van Pesch, Stéphanie, Vicca, Sylvain, Lehmann, Aurélie, Bedel
Publikováno v:
Annales de biologie clinique. 80(5)
Neurofilaments (Nf) are proteins selectively expressed in the cytoskeleton of neurons, and their increase is a marker of neuronal damage. The potential utility of neurofilament light chain (NfL) has recently increased considerably, well beyond neurod
Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology
Autor:
Karim Belarbi, Sylvie Burnouf, Francisco-Jose Fernandez-Gomez, Cyril Laurent, Sophie Lestavel, Martin Figeac, Audrey Sultan, Laetitia Troquier, Antoine Leboucher, Raphaëlle Caillierez, Marie-Eve Grosjean, Dominique Demeyer, Hélène Obriot, Ingrid Brion, Bérangère Barbot, Marie-Christine Galas, Bart Staels, Sandrine Humez, Nicolas Sergeant, Susanna Schraen-Maschke, Anne Muhr-Tailleux, Malika Hamdane, Luc Buée, David Blum
Publikováno v:
Neurobiology of Disease, Vol 43, Iss 2, Pp 486-494 (2011)
Tau pathology is encountered in many neurodegenerative disorders known as tauopathies, including Alzheimer's disease. Physical activity is a lifestyle factor affecting processes crucial for memory and synaptic plasticity. Whether long-term voluntary
Externí odkaz:
https://doaj.org/article/474624de82d042e7851d6576a260bf6a